Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

One-year Efficacy and Tolerance of Myofix Spectacles for the Control of Myopia Progression

NCT07092072 is registered in ClinicalTrials.gov with Novar Corporation as lead sponsor.

NCT NCT07092072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07092072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
One-year Efficacy and Tolerance of Myofix Spectacles for the Control of Myopia Progression
Lead sponsor
Novar Corporation
Phase
Not applicable
Overall status
Completed
Start date
May 23, 2023
Completion date
April 23, 2024
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopia progression